Cargando…

Carboplatin with intravenous and subsequent oral administration of vinorelbine in resected non-small-cell-lung cancer in real-world set-up

OBJECTIVES: Adjuvant cisplatin-based chemotherapy is recommended for routine use in patients with Stage IIA, IIB or IIIA non-small cell lung cancer (NSCLC) after complete resection. Results obtained for Stage IB were not conclusive. While vinorelbine plus cisplatin is the preferred choice after rese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kolek, Vítězslav, Grygárková, Ivona, Koubková, Leona, Skřičková, Jana, Švecová, Jiřina, Sixtová, Dimka, Bartoš, Jiří, Tichopád, Aleš
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521844/ https://www.ncbi.nlm.nih.gov/pubmed/28732018 http://dx.doi.org/10.1371/journal.pone.0181803

Ejemplares similares

Sphingosine kinase-1 predicts overall survival outcomes in non-small cell lung cancer patients treated with carboplatin and navelbine
por: Gachechiladze, Mariam, et al.
Publicado: (2019)

A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas
por: Jancik, Sylwia, et al.
Publicado: (2012)

Carboplatin/vinorelbine: Worsening of lung adenocarcinoma: case report
Publicado: (2022)

Real-Life GOLD 2011 Implementation: The Management of COPD Lacks Correct Classification and Adequate Treatment
por: Koblizek, Vladimir, et al.
Publicado: (2014)

Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity
por: Helbekkmo, N, et al.
Publicado: (2007)

Effectiveness of first-line anticancer treatment may predict treatment response in further lines in stage III/IV patients with non-small cell lung cancer
por: Bratova, Monika, et al.
Publicado: (2023)

Clinical and Economic Burden of Community-Acquired Pneumonia among Adults in the Czech Republic, Hungary, Poland and Slovakia
por: Tichopad, Ales, et al.
Publicado: (2013)

A phase II study of carboplatin and vinorelbine as second-line treatment for advanced breast cancer.
por: Iaffaioli, R. V., et al.
Publicado: (1995)

Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group
por: Fløtten, Ø, et al.
Publicado: (2012)

Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
por: Huang, Liang, et al.
Publicado: (2019)

Metastatic Intimal Sarcoma of the Pulmonary Artery Sensitive to Carboplatin-Vinorelbine Chemotherapy: Case Report and Literature Review
por: Cantaloube, Marie, et al.
Publicado: (2018)

Real‐life effectiveness of first‐line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry
por: Brat, Kristian, et al.
Publicado: (2020)

Outcome and toxicity of ifosfamide, carboplatin, and etoposide versus gemcitabine and vinorelbine regimen for pediatric patients with relapsed or refractory Hodgkin’s lymphoma
por: Mahdy, Ahmed, et al.
Publicado: (2023)

Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
por: Comella, P., et al.
Publicado: (1996)

Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial
por: Huebner, G, et al.
Publicado: (2009)

A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
por: Lerouge, Delphine, et al.
Publicado: (2014)

The Incidence and Predictors of Thromboembolic Events in Patients with Lung Cancer
por: Kadlec, Bohdan, et al.
Publicado: (2014)

Vinorelbine – a clinical review
por: Gregory, R K, et al.
Publicado: (2000)

Oral vinorelbine in metastatic breast cancer
por: Conte, PF, et al.
Publicado: (2005)

Vinorelbine Augments Radiotherapy in Hepatocellular Carcinoma
por: Yeoh, Kheng Wei, et al.
Publicado: (2020)

Pharmacokinetic Study of Carboplatin Given on a 5‐Day Intravenous Schedule
por: Ando, Yuichi, et al.
Publicado: (1997)

Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
por: Baldini, E., et al.
Publicado: (1998)

Validation of kinetics similarity in qPCR
por: Bar, Tzachi, et al.
Publicado: (2012)

Could the new coronavirus have infected humans prior November 2019?
por: Tichopád, Aleš, et al.
Publicado: (2021)

A modified Phase I trial of radiation dose escalation in 3D conformal radiation therapy with concurrent vinorelbine and carboplatin chemotherapy for non-small-cell lung cancer
por: Lin, Qiang, et al.
Publicado: (2013)

Serum concentration and safety of intravenous drip versus subcutaneous administration of carboplatin in dogs
por: IWANO, Masataka, et al.
Publicado: (2021)

Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma
por: Sørensen, J B, et al.
Publicado: (2008)

Fibrin Clot Formation under Oxidative Stress Conditions
por: Kaufmanova, Jirina, et al.
Publicado: (2021)

Chronotropic incompetence could negatively influence post-operative risk assessment in patients before lung cancer surgery
por: Sova, Milan, et al.
Publicado: (2020)

Vinorelbine induced perforation of a metastatic gastric lesion
por: Mullally, W. J., et al.
Publicado: (2016)

Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial
por: Li, Dou-Dou, et al.
Publicado: (2022)

Occupational Pulmonary Aluminosis: A Case Report
por: SMOLKOVÁ, Petra, et al.
Publicado: (2014)

Case of accelerated silicosis in a sandblaster
por: HUTYROVÁ, Beáta, et al.
Publicado: (2014)

The Serum Expression of Selected miRNAs in Pulmonary Sarcoidosis with/without Löfgren's Syndrome
por: Novosadova, Eva, et al.
Publicado: (2016)

Giant cell carcinoma of the lung successfully treated with surgical resection and adjuvant vinorelbine and cisplatin
por: Habib, Saad, et al.
Publicado: (2018)

High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study
por: Liu, Yue-E, et al.
Publicado: (2013)

Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study
por: Serin, D, et al.
Publicado: (2005)

A Phase I Comparative Pharmacokinetic and Safety Study of Two Intravenous Formulations of Vinorelbine in Patients With Advanced Non-Small Cell Lung Cancer
por: Wu, Guolan, et al.
Publicado: (2019)

In Vitro Activity of Water Extracts of Olive Oil against Planktonic Cells and Biofilm Formation of Arcobacter-like Species
por: Švarcová, Karolína, et al.
Publicado: (2022)

Methods of preventing vinorelbine-induced phlebitis: an experimental study in rabbits
por: Kohno, Emiko, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ajk6ja9okq6kgedl0dd8jcajm6